2024-06-28 08:00 Regulatory Annual
Annual report for the financial year 2023/2024 for Biovica International AB is published today on our website. See URL below. Contact Anders Rylander, CEOPhone: +46 76 666 16 47E-mail: anders.rylander@biovica.com Anders Morén, CFOPhone: +46 73...
2023-06-30 08:00 Regulatory Annual
Annual report for the financial year 2022/2023 for Biovica International AB is published today on our website. Biovica International AB - Financial reports Biovica – Treatment decisions with greater confidence Biovica develops and commercializes...
2022-06-30 08:00 Regulatory Annual
Annual report for the financial year 2021/2022 for Biovica International AB is published today on our website. Financials – Biovica Contact Anders Rylander, CEO Phone: +46-18-444 48 35 E-mail: anders.rylander@biovica.com Cecilia Driving, EVP CFO...
2021-06-30 08:00 Regulatory Annual
Annual report for the financial year 2020/2021 for Biovica International AB is published today on our website Financials – Biovica Contact Anders Rylander, CEO Phone: +46-18-444 48 35 E-mail: anders.rylander@biovica.com Cecilia Driving, EVP CFO...
2020-06-30 08:00 Regulatory Annual
Biovica’s annual report for the fiscal year 2019/2020 is published on our website https://biovica.com/investor-relations/financials/ Contact Anders Rylander, CEO Phone: +46-18-444 48 35 E-mail: anders.rylander@biovica.com Cecilia Driving, EVP CFO/HR/IR...
2019-06-28 08:00 Regulatory Annual
”A very positive fiscal year 2018/2019 is summarized in the annual report. For example, we have presented positive results from clinical trials in collaboration with leading oncologists, that has highlighted the value of DiviTum before and during...

>4,500

Numbers of patients in studies

28

Publications

22

Pharma Projects

Are you a US resident?

Only US residents will be able to qualify for this program

No